Cargando…
Mucosal vaccine adjuvants update
Mucosal vaccination, capable of inducing protective immune responses both in the mucosal and systemic immune compartments, has many advantages and is regarded as a blue ocean in the vaccine industry. Mucosal vaccines can offer lower costs, better accessability, needle-free delivery, and higher capac...
Autores principales: | Rhee, Joon Haeng, Lee, Shee Eun, Kim, Soo Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623511/ https://www.ncbi.nlm.nih.gov/pubmed/23596577 http://dx.doi.org/10.7774/cevr.2012.1.1.50 |
Ejemplares similares
-
Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine
por: Lee, Shee Eun, et al.
Publicado: (2015) -
Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB
por: Verma, Vivek, et al.
Publicado: (2016) -
Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1
por: Lee, Hye Hwa, et al.
Publicado: (2022) -
Deimmunization of flagellin for repeated administration as a vaccine adjuvant
por: Khim, Koemchhoy, et al.
Publicado: (2021) -
Intranasal immunization with a flagellin-adjuvanted peptide anticancer vaccine prevents tumor development by enhancing specific cytotoxic T lymphocyte response in a mouse model
por: Nguyen, Chung Truong, et al.
Publicado: (2013)